In urinary bladder cancer, TOP2A has been suggested to be one of the potential therapeutic targets and a prognostic biomarker, as its overexpression has been strongly linked to the progression of the tumor stage and poor prognosis [48]. The gene discussed is TOP2A; the disease is neoplasm.